TRIMTECH Therapeutics
PrivateLast Round
Seed
Jun 23, 2026
Total Funding Raised
$61M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
TRIMTECH Therapeutics is a biotechnology company that is developing a targeted protein degradation platform designed to address neurodegenerative diseases by degrading toxic protein aggregates.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TRIMTECH Therapeutics Comparables
Compare TRIMTECH Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Convergen Suzhou Pharmaceutical Co. Ltd. | 88% | |
| Plexium | 79% | |
| Amphista Therapeutics | 79% |
TRIMTECH Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 23, 2026 | ||||
| Seed | Mar 5, 2025 |
Key People
Founding team and executive leadership
TRIMTECH Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MP Healthcare Venture Management | Seed |
| Start Codon | Seed |
| Cambridge Enterprise Ventures | Seed |
| BGF | Seed |
| M Ventures | Seed |
| Cambridge Innovation Capital | Seed |
| Johnson & Johnson Innovation - JJDC, Inc. | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 76% MoM.
- Jul 28, 2026
Monthly visitors increased 125% MoM, reaching 1.2K.
Recent news
Latest coverage and updates
- receives_awardJul 16, 2026
Trimtech Therapeutics Ltd. receives award o2h Kickstarter Award.
- receives_financingJun 23, 2026
TRIMTECH Therapeutics Limited receives financing of $14M in Seed 1.
- is_developingJun 23, 2026
Trimtech Therapeutics Ltd. is developing TRIMTAC and TRIMGLUE targeted protein degradation portfolio on Jun 23rd '26.
- receives_financingJun 23, 2026
Trimtech Therapeutics Ltd. received financing of $47M in Seed on Jun 23rd '26.
- receives_financingJun 23, 2026
Trimtech Therapeutics Ltd. received financing of $14M in Seed on Jun 23rd '26.
TRIMTECH Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TRIMTECH Therapeutics's valuation, stock price, and market status.
Is TRIMTECH Therapeutics a public or private company?
TRIMTECH Therapeutics is a private company.
What is the current stock price of TRIMTECH Therapeutics?
TRIMTECH Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is TRIMTECH Therapeutics worth (valuation)?
Valuation information for TRIMTECH Therapeutics is not publicly available.
Can I buy TRIMTECH Therapeutics stock?
TRIMTECH Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TRIMTECH Therapeutics's last funding round?
TRIMTECH Therapeutics's most recent funding round was Seed on June 23, 2026.
Who are the main investors in TRIMTECH Therapeutics?
Key investors in TRIMTECH Therapeutics include BGF, Cambridge Innovation Capital, Johnson & Johnson Innovation - JJDC, Inc..
Will TRIMTECH Therapeutics IPO soon?
No public IPO plans have been announced for TRIMTECH Therapeutics.
How can I track TRIMTECH Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TRIMTECH Therapeutics's secondary market activity and sign up for updates.